Henry Schein Inc
NASDAQ:HSIC
Relative Value
The Relative Value of one HSIC stock under the Base Case scenario is 126.82 USD. Compared to the current market price of 72.82 USD, Henry Schein Inc is Undervalued by 43%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
HSIC Competitors Multiples
Henry Schein Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.4B USD | 0.8 | 22.6 | 11.8 | 15.9 | ||
US |
Mckesson Corp
NYSE:MCK
|
70.9B USD | 0.2 | 23.6 | 16.4 | 19.1 | ||
US |
Cencora Inc
NYSE:COR
|
47.8B USD | 0.2 | 25.6 | 13.1 | 18.4 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
25.3B USD | 0.1 | 39.6 | 8.9 | 11.9 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
67.9B HKD | 0.1 | 7 | 1.7 | 2 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.3B CNY | 1.4 | 21.2 | 15.5 | 15.5 | ||
IT |
Amplifon SpA
MIL:AMP
|
7B EUR | 3.1 | 45 | 14.5 | 28.7 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
50.7B CNY | 0.2 | 13.5 | 8 | 8 | |
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.2 | -5.1 | 3.9 | 19.2 |